SEC Form SC 13G/A filed by ChargePoint Holdings Inc. (Amendment)

SEC Form SC 13G/A filed by ChargePoint Holdings Inc. (Amendment)

Recent Analyst Ratings for
$CHPT

$CHPT
Leadership Updates

$CHPT
SEC Filings

$CHPT
Insider Purchases

$CHPT
Insider Trading

$CHPT
Press Releases

$CHPT
Large Ownership Changes

Chat with this insight

Live Leadership Updates

ChargePoint Appoints David Vice as Chief Revenue Officer

ChargePoint Announces Executive and Board Appointments to Bolster Expertise in Software-Led EV Charging

ChargePoint and Airbnb Partner to Enable Seamless EV Charging

Amendment: SEC Form SCHEDULE 13G/A filed by ChargePoint Holdings Inc.

SEC Form S-8 filed by ChargePoint Holdings Inc.

SEC Form 10-K filed by ChargePoint Holdings Inc.

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4: Q-Grg Vii (Cp) Investment Partners, Llc bought $9,990,000 worth of shares (1,850,000 units at $5.40)

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

CLO and Corp Secretary Chavez Rebecca was granted 1,500,000 shares, increasing direct ownership by 128% to 2,673,568 units (SEC Form 4)

CFO Khetani Mansi was granted 1,500,000 shares, increasing direct ownership by 122% to 2,728,978 units (SEC Form 4)

CCXO Singh Jagdeep Ca was granted 1,500,000 shares, increasing direct ownership by 131% to 2,648,360 units (SEC Form 4)

Fastest customizable press release news feed in the world

ChargePoint Innovations Transform EV Charging with Maximum-Speed Bidirectional AC Architecture

ChargePoint Deploys EV Fast Charging in New York with Support from NY State Energy Research and Development Authority

ChargePoint Reports Fourth Quarter and Full Fiscal Year 2025 Financial Results

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by ChargePoint Holdings Inc.

Amendment: SEC Form SC 13G/A filed by ChargePoint Holdings Inc.

2/13/24 6:01:57 PM ET

$CHPT

Industrial Specialties

Consumer Discretionary

Get the next $CHPT alert in real time by email

SC 13G/A 1 d48914dsc13ga.htm SC 13G/A SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

ChargePoint Holdings, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

15961R105

(CUSIP Number)

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 15961R105		13G		Page 2 of 23 Pages

(1)

This statement on Schedule 13G is filed by Linse Capital CP, LLC (“Linse I”), Linse Capital CP II, LLC (“Linse II”), Linse Capital CP III, LLC (“Linse III”), Linse Capital CP IV, LLC (“Linse IV”), Linse Capital CP V, LLC (“Linse V”), Linse Capital CP VI, LLC (“Linse VI”), Linse Capital CP VI GP LP (“Linse GP VI”), Levitate Capital LP (“Levitate”), Levitate Capital GP LP (“Levitate GP”), Linse Capital Management LLC (“LCM”), Linse Capital Management PR LLC (“LCMPR”), Linse Capital LLC (“Linse Capital”) and Michael Linse (“Linse,” together with Linse I, Linse II, Linse III, Linse IV, Linse V, Linse VI, Linse GP VI, Levitate, Levitate GP, LCM, LCMPR and Linse Capital, collectively, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)

This amount consists of shares of Common Stock held by Linse I. Linse is the managing director of Linse Capital, which is the manager of Linse I. Each of Linse and Linse Capital possesses power to direct the voting and disposition of the shares owned by Linse I, and each of Linse and Linse Capital may be deemed to have an indirect beneficial ownership of such shares.

(3)

The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended October 31, 2023, as filed with the Securities and Exchange Commission on December 8, 2023 (the “Form 10-Q”).


CUSIP No. 15961R105		13G		Page 3 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)

This amount consists of shares of Common Stock held by Linse II. Linse is the managing director of Linse Capital, which is the manager of Linse II. Each of Linse and Linse Capital possesses power to direct the voting and disposition of the shares owned by Linse II, and each of Linse and Linse Capital may be deemed to have an indirect beneficial ownership of such shares.

(3)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q.


CUSIP No. 15961R105		13G		Page 4 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)

This amount consists of shares of Common Stock held by Linse III. Linse is the managing director of Linse Capital, which is the manager of Linse III. Each of Linse and Linse Capital possesses power to direct the voting and disposition of the shares owned by Linse III, and each of Linse and Linse Capital may be deemed to have an indirect beneficial ownership of such shares.

(3)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q.


CUSIP No. 15961R105		13G		Page 5 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)

This amount consists of shares of Common Stock held by Linse IV. Linse is the managing director of Linse Capital, which is the manager of Linse IV. Each of Linse and Linse Capital possesses power to direct the voting and disposition of the shares owned by Linse IV, and each of Linse and Linse Capital may be deemed to have an indirect beneficial ownership of such shares.

(3)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q.


CUSIP No. 15961R105		13G		Page 6 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)

This amount consists of (i) 620,358 shares of Common Stock and (ii) warrants to purchase up to an aggregate of 2,166,266 shares of Common Stock that are exercisable within 60 days of the date of filing, in each case held by Linse V. Linse is the managing director of Linse Capital, which is the manager of Linse V. Each of Linse and Linse Capital possesses power to direct the voting and disposition of the shares owned by Linse V, and each of Linse and Linse Capital may be deemed to have an indirect beneficial ownership of such shares.

(3)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q and assuming exercise of all warrants held by Linse V.


CUSIP No. 15961R105		13G		Page 7 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)

This amount consists of (i) 988,377 shares of Common Stock and (ii) warrants to purchase up to an aggregate of 9,389,424 shares of Common Stock that are exercisable within 60 days of the date of filing, in each case held by Linse VI. Linse GP VI is the manager of Linse VI, and LCMPR is the general partner of Linse GP VI. Linse is the managing director of Linse Capital, which is the manager of LCMPR. Each of Linse GP VI, LCMPR, Linse Capital and Linse possesses power to direct the voting and disposition of the shares owned by Linse VI, and each of Linse GP VI, LCMPR, Linse Capital and Linse may be deemed to have an indirect beneficial ownership of such shares.

(3)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q and assuming exercise of all warrants held by Linse VI.


CUSIP No. 15961R105		13G		Page 8 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)

(3)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q and assuming exercise of all warrants held by Linse VI.


CUSIP No. 15961R105		13G		Page 9 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)	Levitate GP is the general partner of Levitate. LCM is the general partner of Levitate GP. LCMPR is the manager of LCM. Linse Capital is the general partner of LCMPR. Mr. Linse is the manager director of Linse Capital.

(3)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q.


CUSIP No. 15961R105		13G		Page 10 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(3)	Levitate GP is the general partner of Levitate. LCM is the general partner of Levitate GP. LCMPR is the manager of LCM. Linse Capital is the general partner of LCMPR. Mr. Linse is the manager director of Linse Capital.

(2)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q.


CUSIP No. 15961R105		13G		Page 11 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(3)	Levitate GP is the general partner of Levitate. LCM is the general partner of Levitate GP. LCMPR is the manager of LCM. Linse Capital is the general partner of LCMPR. Mr. Linse is the manager director of Linse Capital.

(2)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q.


CUSIP No. 15961R105		13G		Page 12 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)

(3)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q and assuming exercise of all warrants held by Linse VI.


CUSIP No. 15961R105		13G		Page 13 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)

This amount consists of (i) 2,597,280 shares of Common Stock held by Linse I, (ii) 752,052 shares of Common Stock held by Linse II, (iii) 846,170 shares of Common Stock held by Linse III, (iv) 585,638 shares of Common Stock held by Linse IV, (v) 620,358 shares of Common Stock and warrants to purchase up to 2,166,266 shares of Common Stock, which are exercisable within 60 days of the date hereof held by Linse V, and (vi) 988,377 shares of Common Stock and warrants to purchase up to 9,389,424 shares of Common Stock, which are exercisable within 60 days of the date hereof held by Linse VI. Linse is the managing director of Linse Capital, which is the manager of Linse I, Linse II, Linse III, Linse IV, and Linse V, and the manager of LCMPR. LCMPR is the manager of Linse VI and LCM, and the general partner of Linse GP VI. LCM is the general partner of Levitate GP. Levitate GP is the general partner of Levitate. Each of Linse and Linse Capital possesses power to direct the voting and disposition of the Securities owned by Linse I, Linse II, Linse III, Linse IV, Linse V, Linse VI, Linse GP VI, Levitate, Levitate GP, LCM and LCMPR and each of Linse and Linse Capital may be deemed to have an indirect beneficial ownership of such shares.

(3)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q and assuming exercise of all warrants held by Linse V and Linse VI.


CUSIP No. 15961R105		13G		Page 14 of 23 Pages

(1)	This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)

(3)	The percentages set forth on the cover sheets are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q and assuming exercise of all warrants held by Linse V and Linse VI.


CUSIP No. 15961R105		13G		Page 15 of 23 Pages

This Amendment No. 2 to the statement on Schedule 13G (this “Amendment No. 2”) amends and restates the statement on Schedule 13G filed on February 14, 2022 (the “Schedule 13G”).

Item 1(a). Name of Issuer:

ChargePoint Holdings, Inc.

Item 1(b). Address of Issuer’s Principal Executive Officers:

240 East Hacienda Avenue

Campbell, CA 95008

Item 2(a). Name of Person(s) Filing:

Linse Capital CP, LLC (“Linse I”)

Linse Capital CP II, LLC (“Linse II”)

Linse Capital CP III, LLC (“Linse III”)

Linse Capital CP IV, LLC (“Linse IV”)

Linse Capital CP V, LLC (“Linse V”)

Linse Capital CP VI, LLC (“Linse VI”)

Linse Capital CP VI GP LP (“Linse GP VI”)

Levitate Capital LP (“Levitate”)

Levitate Capital GP LP (“Levitate GP”)

Linse Capital Management (“LCM”)

Linse Capital Management PR LLC (“LCMPR”)

Linse Capital LLC (“Linse Capital”)

Michael Linse (“Linse”)

Item 2(b). Address of Principal Business Office:

Linse Capital LLC

53 Calle Palmeras, Suite 601

San Juan, PR 00901

Item 2(c). Citizenship:

Linse I

Linse II

Linse III

Linse IV

Linse V

Delaware, United States of America


CUSIP No. 15961R105		13G		Page 16 of 23 Pages


Linse VI		Delaware, United States of America
Linse GP VI		Delaware, United States of America
Levitate		Delaware, United States of America
Levitate GP		Delaware, United States of America
LCM		Delaware, United States of America
LCMPR		Delaware, United States of America
Linse Capital		Delaware, United States of America
Linse		United States of America

Item 2(d). Title of Class of Securities:

Common Stock, par value $0.0001 per share.

Item 2(e). CUSIP Number:

15961R 105

Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

Not applicable.

Item 4(a). Amount Beneficially Owned: 17,945,565

Item 4(b). Percent of Class: 4.2%

Item 4(c). Number of shares as to which such persons have:

The following information with respect to the beneficial ownership of Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2023:


Reporting Persons	Shares Held Directly		Sole Voting Power		Shared Voting Power (1)		Sole Dispositive Power		Shared Dispositive Power (1)		Beneficial Ownership (1)		Percentage of Class (1,3)
Linse I (2)		2,597,280		0		2,597,280		0		2,597,280		2,597,280		0.6	%
Linse II (2)		752,052		0		752,052		0		752,052		752,052		0.2	%
Linse III (2)		846,170		0		846,170		0		846,170		846,170		0.2	%
Linse IV (2)		585,638		0		585,638		0		585,638		585,638		0.1	%
Linse V (2)		2,786,624		0		2,786,624		0		2,786,624		2,786,624		0.7	%
Linse VI (2)		10,377,801		0		10,377,801		0		10,377,801		10,377,801		2.4	%
Linse GP VI (2)		0		0		10,377,801		0		10,377,801		10,377,801		2.4	%
LCMPR (2)		0		0		10,377,801		0		10,377,801		10,377,801		2.4	%
Linse Capital (2)		0		0		17,945,565		0		17,945,565		17,945,565		4.2	%
Linse (2)		0		0		17,945,565		0		17,945,565		17,945,565		4.2	%

(1)

Represents the number of shares of Common Stock and the number of shares of Common Stock issuable upon exercise of options, warrants and other convertible securities that are exercisable within 60 days of the date of this statement on Schedule 13G (“Securities”) currently beneficially owned by the Reporting Persons.


CUSIP No. 15961R105		13G		Page 17 of 23 Pages

(2)

Linse is the managing director of Linse Capital, which is the manager of Linse I, Linse II, Linse III, Linse IV and Linse V, and the manager of LCMPR. LCMPR is the manager of Linse VI and LCM, and the general partner of Linse GP VI. LCM is the general partner of Levitate GP. Levitate GP is the general partner of Levitate. Each of Linse and Linse Capital possesses power to direct the voting and disposition of the Securities owned by Linse I, Linse II, Linse III, Linse IV, Linse V, Linse VI, Linse GP VI, Levitate, Levitate GP, LCM and LCMPR and each of Linse and Linse Capital may be deemed to have an indirect beneficial ownership of such Securities.

(3)	The percentages set forth above are calculated based on 418,027,891 shares of Common Stock outstanding as of December 1, 2023 as set forth in the Form 10-Q.

Item 5. Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof, the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒

Item 6. Ownership of More Than Five Percent on Behalf of Another Person:

Not applicable.

Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not applicable.

Item 8. Identification and Classification of Members of the Group:

Not applicable.

Item 9. Notice of Dissolution of Group:

Not applicable.

Item 10. Certification:

Not applicable.


CUSIP No. 15961R105		13G		Page 18 of 23 Pages

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 13, 2024


LINSE CAPITAL CP, LLC

By:		Linse Capital LLC
		a Delaware limited liability company and Manager of Linse Capital CP, LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director

LINSE CAPITAL CP II, LLC

By:		Linse Capital LLC
		a Delaware limited liability company and Manager of Linse Capital CP II, LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director

LINSE CAPITAL CP III, LLC

By:		Linse Capital LLC
		a Delaware limited liability company and Manager of Linse Capital CP III, LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director

LINSE CAPITAL CP IV, LLC

By:		Linse Capital LLC
		a Delaware limited liability company and Manager of Linse Capital CP IV, LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director

LINSE CAPITAL CP V, LLC

By:		Linse Capital LLC
		a Delaware limited liability company and Manager of Linse Capital CP V, LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director


CUSIP No. 15961R105		13G		Page 19 of 23 Pages


LINSE CAPITAL CP VI, LLC

By:		Linse Capital CP VI GP LP
		a Delaware limited partnership and Manager of Linse Capital CP VI, LLC

By:		Linse Capital Management PR LLC
		a Delaware limited liability company and Manager of Linse Capital CP VI GP LP

By:		Linse Capital LLC
		a Delaware limited liability company and Manager of Linse Capital Management PR LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director

LINSE CAPITAL CP VI GP LP

By:		Linse Capital Management PR LLC
		a Delaware limited liability company and Manager of Linse Capital CP VI GP LP

By:		Linse Capital LLC
		a Delaware limited liability company and Manager of Linse Capital Management PR LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director

LEVITATE CAPITAL LP

By:		Levitate Capital GP LP a Delaware limited partnership and General Partner of Levitate Capital LP

By:		Linse Capital Management LLC, a Delaware limited liability company and General Partner of Levitate Capital GP LP

By:		Linse Capital Management PR LLC, a Delaware limited liability company and Manager of Linse Capital Management LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director


CUSIP No. 15961R105		13G		Page 20 of 23 Pages


LEVITATE CAPITAL GP LP

By:		Linse Capital Management LLC, a Delaware limited liability company and General Partner of Levitate Capital GP LP

By:		Linse Capital Management PR LLC, a Delaware limited liability company and Manager of Linse Capital Management LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director

LINSE CAPITAL MANAGEMENT LLC

By:		Linse Capital Management PR LLC, a Delaware limited liability company and Manager of Linse Capital Management LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director

LINSE CAPITAL MANAGEMENT PR LLC

By:		Linse Capital LLC
		a Delaware limited liability company and Manager of Linse Capital Management PR LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director

LINSE CAPITAL LLC

By:		/s/ Michael Linse
		Michael Linse, Managing Director

/s/ Michael Linse

Michael Linse

Exhibit(s):


99.1:		Joint Filing Statement

Get the next $CHPT alert in real time by email

Date	Price Target	Rating	Analyst
3/31/2025	$4.00 → $1.00	Outperform → In-line	Evercore ISI
11/19/2024		Buy → Hold	Needham
10/3/2024		Overweight → Underweight	JP Morgan
9/5/2024	$2.00	Buy → Hold	TD Cowen
9/5/2024		Peer Perform	Wolfe Research
4/9/2024	$2.00 → $1.50	Neutral → Sell	Goldman
3/6/2024	$3.50 → $3.00	Outperform → Sector Perform	RBC Capital Mkts
2/21/2024	$4.25	Buy	The Benchmark Company

NAMES OF REPORTING PERSONS

Linse Capital CP, LLC

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) ☐ (b) ☒ (1)

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware, United States of America